Your Risk For
Preterm Birth
About FDA–Approved
Makena
Makena
Care Connection
Useful Information En Español
  • Your Risk Factors
  • |
  • Reducing Your Risk
  • What Is Makena?
  • |
  • How Makena Can Help
  • |
  • How Safe Is Makena?
  • |
  • Using Makena
  • |
  • Benefits Of FDA Approval
  • Makena Access
  • Educational Materials
  • |
  • Tell A Friend
  • Acceso a Makena
  • |
  • Materiales educativos
  • |
  • Cuénteselo a una amiga

Contact us

For Patients


Home

Your Risk For Preterm Birth
Your Risk Factors
Reducing Your Risk

About FDA-Approved Makena
What Is Makena?
How Makena Can Help
How Safe Is Makena?
Using Makena
Benefits Of FDA Approval

Makena Care Connection
Makena Access

Useful Information
Educational Materials
Tell A Friend

En Español
Acceso a Makena
Materiales educativos
Cuénteselo a una amiga

Footer Menu
Home
Contact Us
Site Directory
Safety Information
Prescribing Information
About Ther-Rx

Terms of Use of Site

For Healthcare Providers


Home

Prescribing Information

About Makena
Dosing
Efficacy
Safety — Baby
Safety — Mom

The Makena Difference

Makena Care Connection
Benefits
Financial Assistance
Forms
Ordering Makena
Return Policy

Pharmacists

Resources
Patient Materials

Footer Menu
Home
Contact Us
Site Directory
Safety Information
Prescribing Information
About Ther-Rx

Terms of Use of Site

For Office Administrators


Home

How to Prescribe Makena
Two Ways to Obtain Makena
Makena Care Connection
Ordering and Stocking Makena

Purchasing and Stocking Makena
Billing and Coding Process
FAQs

Patient Financial Assistance
Financial Assistance

Resources
Forms, Guides, and Templates
Order Patient Materials
Download Patient Materials

Footer Menu
Home
Contact Us
Site Directory
Safety Information
Prescribing Information
About Ther-Rx

Terms of Use of Site

Makena® is a prescription hormone medicine (progestin) used to lower the risk of preterm birth in women who are pregnant with one baby and who have delivered one baby too early (preterm) in the past. Makena was shown to work based on a lower number of women who delivered babies at less than 37 weeks of pregnancy. There are no studies showing Makena reduces the number of babies who have serious problems shortly after birth or who die. It is not known whether Makena is safe and effective in women who have other risk factors for preterm birth.

Important safety information for Makena (hydroxyprogesterone caproate injection)

Makena should not be used in women with any of the following conditions: blood clots or other blood clotting problems, breast cancer or other hormone-sensitive cancers, or history of these conditions; unusual vaginal bleeding not related to your current pregnancy, yellowing of the skin due to liver problems during pregnancy, liver problems, including liver tumors, or uncontrolled high blood pressure.

Before you receive Makena, tell your healthcare provider if you have an allergy to hydroxyprogesterone caproate, castor oil, or any of the other ingredients in Makena; diabetes or prediabetes, epilepsy, migraine headaches, asthma, heart problems, kidney problems, depression, or high blood pressure.

In a clinical study, certain complications or events associated with pregnancy occurred more often in women who received Makena. These included miscarriage (pregnancy loss before 20 weeks of pregnancy), stillbirth (fetal death occurring during or after the 20th week of pregnancy), hospital admission for preterm labor, preeclampsia (high blood pressure and too much protein in your urine), gestational hypertension (high blood pressure caused by pregnancy), gestational diabetes, and oligohydramnios (low amniotic fluid levels).

Makena may cause serious side effects including blood clots, allergic reactions, depression, and yellowing of your skin and the whites of your eyes. Call your healthcare provider right away if you think you have symptoms of a blood clot (leg swelling, redness in your leg, a spot on your leg that is warm to touch, or leg pain that worsens when you bend your foot) or symptoms of an allergic reaction (hives, itching, or swelling of the face). The most common side effects of Makena include injection site reactions (pain, swelling, itching, bruising, or a hard bump), hives, itching, nausea, and diarrhea.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Makena® is a prescription hormone medicine (progestin) used to lower the risk of preterm birth in women who are pregnant with one baby and who have delivered one baby too early (preterm) in the past. Makena was shown to work based on a lower number of women who delivered babies at less than 37 weeks of pregnancy. There are no studies showing Makena reduces the number of babies who have serious problems shortly after birth or who die. It is not known whether Makena is safe and effective in women who have other risk factors for preterm birth.

Important safety information for Makena (hydroxyprogesterone caproate injection)

Makena should not be used in women with any of the following conditions: blood clots or other blood clotting problems, breast cancer or other hormone-sensitive cancers, or history of these conditions; unusual vaginal bleeding not related to your current pregnancy, yellowing of the skin due to liver problems during pregnancy, liver problems, including liver tumors, or uncontrolled high blood pressure.

Before you receive Makena, tell your healthcare provider if you have an allergy to hydroxyprogesterone caproate, castor oil, or any of the other ingredients in Makena; diabetes or prediabetes, epilepsy, migraine headaches, asthma, heart problems, kidney problems, depression, or high blood pressure.

In a clinical study, certain complications or events associated with pregnancy occurred more often in women who received Makena. These included miscarriage (pregnancy loss before 20 weeks of pregnancy), stillbirth (fetal death occurring during or after the 20th week of pregnancy), hospital admission for preterm labor, preeclampsia (high blood pressure and too much protein in your urine), gestational hypertension (high blood pressure caused by pregnancy), gestational diabetes, and oligohydramnios (low amniotic fluid levels).

Makena may cause serious side effects including blood clots, allergic reactions, depression, and yellowing of your skin and the whites of your eyes. Call your healthcare provider right away if you think you have symptoms of a blood clot (leg swelling, redness in your leg, a spot on your leg that is warm to touch, or leg pain that worsens when you bend your foot) or symptoms of an allergic reaction (hives, itching, or swelling of the face). The most common side effects of Makena include injection site reactions (pain, swelling, itching, bruising, or a hard bump), hives, itching, nausea, and diarrhea.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see full prescribing information for Makena.





  • Home
  • |
  • Contact Us
  • |
  • Site Directory
  • |
  • Safety Information
  • |
  • Prescribing Information
  • |
  • About Ther-Rx

Ther-Rx
©2012 Ther-Rx Corporation Terms of Use of Site